1Rosenson RS,Tangney CC. Antiatherothromboic properties of stains. Implications for cardiovascular event reduction..JAMA, 1998,279:1643 ～ 1650.
2Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient. A call for new definition and risk assessment strategies:part 1 and part Ⅱ. Circulation,2003, 108:1664 ～ 1778.
3Falk E. Why do plaques repture? Circulation, 1992,86:Ⅲ 30 -42.
4Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl JMed, 1997,336:1276 ～ 1282.
5Ross R. Atherosclerosis - an inflammatory disease. N Eng J Med, 1999,340:115 - 126.
6Koerig W. Inflammation and coronary heart disease: an overview. Cardiol Rev,2001,9:31 ～35.
7Yu H Rifin N. High sensitiviey CRP and atherosclerosis,from theory to therapy clinic. Biochemistry ,2000,33:601 ～ 610.
8Lendon CL, Davies M.J, Bom GVR, et al. Atherosclerotic plaque caps are localy weakened when macrophages density increased. Atherosclerosis,1991,87:87 ～90.
9Biassuci LM,D'Onofrio G,Liuzzo G,et al. Intercellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischaemia. J AM Coll Cardiol,1996,27:611 ～ 616.
